- Home
- VFS vs BBIO Comparison
VFS vs BBIO Comparison
Compare VFS & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFS
- BBIO
- Stock Information
- Founded
- VFS 2017
- BBIO 2015
- Country
- VFS Vietnam
- BBIO United States
- Employees
- VFS N/A
- BBIO N/A
- Industry
- VFS Blank Checks
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- VFS Finance
- BBIO Health Care
- Exchange
- VFS Nasdaq
- BBIO Nasdaq
- Market Cap
- VFS 6.8B
- BBIO 6.7B
- IPO Year
- VFS N/A
- BBIO 2019
- Fundamental
- Price
- VFS $3.50
- BBIO $33.34
- Analyst Decision
- VFS Strong Buy
- BBIO Strong Buy
- Analyst Count
- VFS 4
- BBIO 12
- Target Price
- VFS $8.17
- BBIO $57.09
- AVG Volume (30 Days)
- VFS 422.5K
- BBIO 3.5M
- Earning Date
- VFS 05-30-2025
- BBIO 04-29-2025
- Dividend Yield
- VFS N/A
- BBIO N/A
- EPS Growth
- VFS N/A
- BBIO N/A
- EPS
- VFS N/A
- BBIO N/A
- Revenue
- VFS $1,727,262,130.00
- BBIO $127,415,000.00
- Revenue This Year
- VFS N/A
- BBIO $89.10
- Revenue Next Year
- VFS $44.69
- BBIO $57.07
- P/E Ratio
- VFS N/A
- BBIO N/A
- Revenue Growth
- VFS 57.87
- BBIO N/A
- 52 Week Low
- VFS $2.56
- BBIO $21.62
- 52 Week High
- VFS $5.38
- BBIO $39.54
- Technical
- Relative Strength Index (RSI)
- VFS 51.02
- BBIO 43.58
- Support Level
- VFS $3.45
- BBIO $32.70
- Resistance Level
- VFS $3.60
- BBIO $34.44
- Average True Range (ATR)
- VFS 0.12
- BBIO 1.32
- MACD
- VFS -0.03
- BBIO -0.31
- Stochastic Oscillator
- VFS 13.51
- BBIO 18.23
About VFS VinFast Auto Ltd.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Automobiles, E-scooter, Spare parts & Aftermarket services. The Automobiles segment includes the design, development, manufacturing, and sales of cars and electric buses; The E-scooter segment includes the design, development, manufacturing, and sales of e-scooters; the Spare parts & Aftermarket services segment includes the sales of spare parts and rendering of aftermarket services for automobiles and e-scooters.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.